Autoimmune hemolytic anemia: causes and consequences
B Fattizzo, W Barcellini - Expert review of clinical immunology, 2022 - Taylor & Francis
Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct
antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold …
antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold …
Hematologic complications of immune checkpoint inhibitors
MH Kroll, C Rojas-Hernandez… - Blood, The Journal of the …, 2022 - ashpublications.org
Immune checkpoint inhibitors are a class of antineoplastic therapies that unleash immune
cells to kill malignant cells. There are currently 7 medications that have been approved by …
cells to kill malignant cells. There are currently 7 medications that have been approved by …
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink
TJ González-López, D Provan, A Bárez… - Blood Reviews, 2023 - Elsevier
There are not many publications that provide a holistic view of the management of primary
and secondary ITP as a whole, reflecting the similarities and differences between the two …
and secondary ITP as a whole, reflecting the similarities and differences between the two …
Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias
W Barcellini, B Fattizzo - Expert Review of Hematology, 2023 - Taylor & Francis
Introduction The direct antiglobulin test (DAT) or Coombs test is the cornerstone of the
diagnosis of autoimmune hemolytic anemia (AIHA). It can be performed by several methods …
diagnosis of autoimmune hemolytic anemia (AIHA). It can be performed by several methods …
Paraneoplastic syndromes review: The great forgotten ones
CS González, CM Vivero, JL Castro - Critical Reviews in Oncology …, 2022 - Elsevier
Paraneoplastic syndromes (PNS) are a group of disorders that can affect the oncologic
patient, and which are not directly attributable to tumour invasion, tumour compression or …
patient, and which are not directly attributable to tumour invasion, tumour compression or …
The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy
T Moulinet, A Moussu, L Pierson, S Pagliuca - Blood Reviews, 2023 - Elsevier
Immune thrombocytopenia (ITP) is a rare autoimmune condition, due to peripheral platelet
destruction through antibody-dependent cellular phagocytosis, complement-dependent …
destruction through antibody-dependent cellular phagocytosis, complement-dependent …
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: a comprehensive review
F Autore, R Pasquale, I Innocenti, A Fresa, F Sora'… - Cancers, 2021 - mdpi.com
Simple Summary This review analyzes the occurrence, clinical characteristics, and
prognostic impact and treatment of autoimmune hemolytic anemia (AIHA) in chronic …
prognostic impact and treatment of autoimmune hemolytic anemia (AIHA) in chronic …
Low-risk myelodysplastic syndrome revisited: morphological, autoimmune, and molecular features as predictors of outcome in a single center experience
B Fattizzo, GV Levati, JA Giannotta… - Frontiers in …, 2022 - frontiersin.org
Low-risk myelodysplastic syndromes (LR-MDS) are a very heterogeneous disease, with
extremely variable clinical features and outcome. Therapeutic strategies are still limited and …
extremely variable clinical features and outcome. Therapeutic strategies are still limited and …
GATA 2 deficiency: focus on immune system impairment
GATA2 deficiency is a disease with a broad spectrum of clinical presentation, ranging from
lymphedema, deafness, pulmonary dysfunction to miscarriage and urogenital anomalies …
lymphedema, deafness, pulmonary dysfunction to miscarriage and urogenital anomalies …
Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from lupus
Introduction Medicine stands at the threshold of a new era heralded by the vast potential of
cell engineering. Like advances made possible by genetic engineering, current prospects …
cell engineering. Like advances made possible by genetic engineering, current prospects …